Seattle Childrens Hospital ( Site 0103) is a clinical research site located in Seattle, Washington, United States 98105.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
Seattle Childrens Hospital ( Site 0103) has participated in 1 clinical trials.
Therapeutic areas: PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome.
Sponsors: ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA).
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Seattle Childrens Hospital ( Site 0103) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Seattle Childrens Hospital ( Site 0103) has 1 clinical trials on record. Their work covers PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome.
Seattle Childrens Hospital ( Site 0103) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.